CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-10-19 | Powell Lynne Senior VP - CCO | Sale | −100 | $7.50 | $750 | 10,149 |
| 2018-10-03 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +972 | $3.22 | $3K | 138,355 |
| 2018-10-03 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −972 | $7.26 | $7K | 137,383 |
| 2018-10-03 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +100 | $3.78 | $378 | 137,483 |
| 2018-10-03 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −100 | $7.45 | $745 | 137,383 |
| 2018-10-03 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −972 | 122,927 | ||
| 2018-10-03 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −100 | 52,455 | ||
| 2018-10-02 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +3,250 | $3.78 | $12K | 140,633 |
| 2018-10-02 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −3,250 | $7.19 | $23K | 137,383 |
| 2018-10-02 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +5,528 | $3.22 | $18K | 142,911 |
| 2018-10-02 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −5,528 | $7.27 | $40K | 137,383 |
| 2018-10-02 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −3,250 | 52,555 | ||
| 2018-10-02 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −5,528 | 123,899 | ||
| 2018-08-09 | Sheridan William P Senior VP - CMO | Option exercise | +62,500 | $1.42 | $89K | 85,713 |
| 2018-08-09 | Sheridan William P Senior VP - CMO | Sale | −62,500 | $7.03 | $439K | 23,213 |
| 2018-08-09 | Sheridan William P Senior VP - CMO | Option exercise · Emp. Stock Option (Right to Buy) | −62,500 | 0 | ||
| 2018-06-20 | LEE KENNETH B JR Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2018-06-20 | INGRAM ROBERT ALEXANDER Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2018-06-20 | Hutson Nancy J Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2018-06-20 | Erck Stanley C Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 |
Page 36 of 38 · 750 trades